Skip to main content

Table 4 Patients Using Lyophilized Preparations*

From: Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens

    

Monthly Dose

No. of Infusions

Details per Infusion

Patient

Patient

Age

Weight

  

Per

Per

Dose

Volume

No. of

Duration

mL/kg/

No.

Name

(yr)

(kg)

(g)

(mg/kg)

Week

Month

(g)

(cc)

Sites

(h)

h/site

13

AT

15

40.0

30

750

1-2

5

6

40

2

8-9

0.059

14

CS

10

42.4

24

566

1

4

6

40

2

2-3

0.019

15

KA

14

65.8

24

365

1

4

6

40

2

2-3

0.121

16

LF

84

68.0

48

705

1

4

12

80

2

2-3

0.235

17

MC

22

70.9

60

845

1

4

12

80

4

2-3

0.112

18

WT

42

75.8

72

979

3

12

6

40

2

2

0.132

19

TSR

36

108.5

60

593

2-3

10

6

40

2

2

0.092

20

SR

49

124.0

54

433

1-2

5†

12

80

2

3-4

0.092

  1. *Carimune NF or Panglobulin NF, unit dose of 6 g reconstituted with 40 cc of sterile water to give an immunoglobulin G concentration of 15%.
  2. †One infusion per month is only 6 g.
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us